|
|
|
Volumn 9, Issue 2, 1999, Pages 131-137
|
|
Cancer HIV-associated hodgkin's disease
|
|
Author keywords
Epstein Barr virus (EBV); Hodgkin's disease; Human immunodeficiency syndrome (HIV)
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIRETROVIRUS AGENT;
BLEOMYCIN;
BLEOMYCIN SULFATE;
DACARBAZINE;
DOXORUBICIN;
EPIRUBICIN;
PHARMARUBICIN;
PREDNISONE;
PROCARBAZINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
UNCLASSIFIED DRUG;
VINBLASTINE;
VINBLASTINE SULFATE;
VINCRISTINE;
VINCRISTINE SULFATE;
ZIDOVUDINE;
ARTICLE;
BACTERIAL INFECTION;
CLINICAL FEATURE;
DISEASE ASSOCIATION;
DRUG ABUSE;
EPSTEIN BARR VIRUS;
HODGKIN DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
OPPORTUNISTIC INFECTION;
SURVIVAL RATE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CAUSE OF DEATH;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
PROGNOSIS;
REVIEW;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CAUSE OF DEATH;
HODGKIN DISEASE;
HUMANS;
PROGNOSIS;
|
|
EID: 0038100503
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (32)
|
